Brain injury acquired antenatally remains a major cause of long-term neurodevelopmental sequelae. (Saigal & Doyle, 2008) There is growing clinical and experimental evidence for maternal and fetal infection acting via systemic and neuroinflammation to cause fetal brain injury or contributing to in utero asphyxial brain injury with consequences for postnatal health. (Rees & Inder, 2005; Murthy & Kennea, 2007; Hagberg et al., 2002; Wang et al., 2006; Gotsch et al., 2007; Fahey, 2008) However, little is known about the roles of brain's glial cells, microglia and astrocytes, in the initiation and maintenance of neuroinflammation in utero and postnatally.
We developed a protocol to culture pure fetal sheep microglia and astrocytes and expose them under in vitro conditions to a stimulus of choice, such as lipopolysaccharide (LPS), allowing a more mechanistic study of their function.
Protocol

Ethics Statement
This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The respective in vivo and in vitro protocols were approved by the Committee on the Ethics of Animal Experiments of the Université de Montréal (Permit Number: 10-Rech-1560).
Anesthesia and surgical procedure
We refer the reader to our previous report. 
In vivo experimental protocol
The in vivo protocol has been reported elsewhere. Briefly, postoperatively, all animals were allowed 3 days to recover before starting the experiments. On these 3 days, at 9.00 am 3 mL arterial plasma sample were taken for blood gases and cytokine analysis. The in vivo protocol can vary depending on the experimental design. Therefore, it is not presented here.
Fetal sheep brain tissue dissection and cells isolation
Fetal sheep brain tissues were obtained during sheep autopsy after completion of the experiment for in vitro study (Figure 1a ). The non-instrumented, untreated twins were designated "naïve" (NC, no exposure, such as LPS, or drug treatment in vivo) and NL when exposed to LPS in vitro for the first time. Fetal sheep microglia culture protocol was adapted from an established human adult and fetal microglia culture protocol that was modified to include a myelin removal step following high-speed centrifugation. (Durafourt et al., 2013) 2.4.1) In the autopsy room, extract the entire brain from fetal skull. Weigh the brain. 2.4.5) Remove all meninges quickly and efficiently to avoid fibroblast contamination, remove brainstem and white matter, only use cortex.
2.4.6) Transfer the cleaned brain cortex on a new Petri dish. Cut brain into <1mm pieces (as pulp), using scalpels.
2.4.7) Transfer brain tissue to a 100ml glass bottle, add 1x PBS to a final volume of about 60ml. 2.4.9 ) Place bottle in shaking water bath and incubate at 37°C, 180rpm for 30min.
2.4.10 ) Add 10%FCS after digestion to stop tissue digestion (add 8ml FCS in about 80ml).
2.4.11 ) Prepare the mesh filter (140μm, autoclaved), place it over a 500ml bottle to collect tissue suspension.
2.4.12 ) Pour a small proportion of tissue mixture onto filter every time, use a 20ml syringe to push down and let the mix tissue pass through the filter. 2.4.28 ) Centrifuge at 1200 rpm for 10min on high brakes to remove Percoll.
2.4.29 ) In the mean time, warm up 5% DMEM bottle at 37°C water bath (for 500ml all-dressed DMEM, adding 25ml FCS (5% for microglia, *10% for astrocyte*), 5ml glutamine (1%), 100μl
Penicillin/Streptomycin antibiotics, 10,000U/ml).
2.4.30 ) After centrifugation, the pellet will be extremely small. Pour off all the supernatant carefully, although the pellet is a lot more stable at this point. 2.6.3) Repeat step 2.6.2 for 4-5 times; the cells passage procedure takes 4-5 weeks until purified astrocytes can be used for treatment.
2.6.4) Plate pure astrocytes into 24-well plate at 1 x 10 5 cells/mL with 10% DMEM for another 7 days ( Figure 1b , Right panel), and then treat with or without LPS for 6h. We chose LPS here as an example of an in vitro stimulus; this can be changed depending on your research question. 2.7.11) In this assay, the sensitivity of IL-1β ELISA was 41.3 pg/ml, the intra-assay and inter-assay coefficients of variance was <5% and <10%, respectively.
Immunocytochemistry (ICC) analysis
2.8.1) Culture and treat cells in chamber slides (microglia see 2.5.7 or astrocyte see 2.6.6); after media removal, fix with 1% formaldehyde for 10min.
2.8.2) Gently wash 3 times for 5min each with PBS, then block with PBST (PBS with 0.3% Triton-100) for 20min. 2.8.6) For microglia purity test, in control wells incubate astrocytes with GFAP-Cy3 (Sigma C9205) at a dilution of 1:500, as negative control, whereas for astrocytes purity test, those astrocytes wells are positive (Figure 1c ).
2.8.7) Capture images with an immunofluorescence inverted microscope (Carl Zeiss Axiovert 200).
RNAseq approach
To demonstrate the RNAseq approach, a total of 6 samples from 3 sets of replicates were selected for RNA sequencing at high throughput on next generation sequencer, of which 3 samples were controls and 3 were exposed to LPS in vitro.
2.9.1) To extract and quantify RNA, extract the total RNA from cultured microglia using TRIzol Reagent (Life Technologies).
2.9.2) Establish RNA quantity and quality (RNA integrity number, RIN) using a RNA Nano Chips (Agilent RNA 6000 Nano Chips) with Agilent 2100 BioAnalyzer. For quality control, all samples should have a RIN value above 6. In our experiment all samples had a RIN value above 6 except for one sample having RIN=5.5 but an acceptable 84% of transcripts mapped which did not affect the read count for this sample. 2.10.2.1) Use DESeq2 to normalize the dataset, generate log2-fold changes and adjacent P values (padj). (Love et al., 2014) In order to minimize the false discovery rate to less than 10%, threshold the dataset of differentially expressed (DE) genes to padj < 0.1. The dataset can also be filtered for more stringent Log2 fold change of, for example, greater than |2| (Figure 2 ). In our experiment, in order to find DE gene in the 3 in vitro LPS challenged samples versus 3 controls (Figure 1a) . We suggest to perform qRT-PCR validation against GADPH for significant DE genes, however potential causal network and interaction relationships should be validated by additional experiments.
Statistical analyses
Cytokine responses in cell culture supernatant were analyzed using GraphPad Prism 5.0 (GraphPad Software, Inc, San Diego, CA). The results were presented as means ± SEM of at least 3 independent replicates as detailed in the figure legend. Data were analyzed by t-test within the same cell type, statistical significance was defined at p < 0.05 (*).
Results
Primary fetal sheep microglia and astrocytes culture
In vitro studies were conducted in primary cultures derived from six controls (naïve) animals.
We were able to perform 1-2 in vitro replicates per each animal depending on cell numbers obtained. The total cell numbers per preparation varied from 24-65 million cells per brain and were heterogeneous, with the majority of microglial cells and astrocytes ( Figure 1b , Left panel), but also including oligodendrocytes and neurons (data not shown). To enrich for microglia or astrocytes we subjected the cells to a second step as detailed in
Methods. Primary microglia were round in shape, whereas astrocytes were elongated in morphology ( Figure 1b , Middle and Right panels). To verify cell culture purity, we performed ICC with microglia and astrocyte markers confirming that the isolated primary microglia and astrocytes were high ( Figure 1c ).
Next, we investigated cytokine secretion properties of these cells in the absence or presence of LPS. We found that in vitro LPS administration resulted in increased IL-1β compared to control in both cultured microglia (p<0.05) and astrocytes (p<0.01, Figure 1d ), indicating cells were responding adequately to the stimulus.
RNAseq approach
We focused the transcriptome analysis on microglia only leaving astrocytes RNAseq for future studies. We identified a large population of genes as differentially expressed. We considered a gene to be DE, if its adjacent p-value was lower than 0.1, equivalent to a false discovery rate of 10%. Also, among the DE genes identified, positive and negative Log2 fold changes were interpreted as up and down regulation, respectively. Applying more stringent conditions such as lowering the adjacent p-value and, or, increasing the threshold of Log2 fold change can decrease the population size of DE genes for further downstream analysis (Figure 2 ).
General overview of the whole transcriptome sequencing
We sequenced the transcriptome of naïve microglia and, as a quality control, we tested the expression levels of GFAP and TNFα across our comparisons. We confirmed that all cells in our platform shared the same gene expression characteristics of microglia (Table 1) . As a control measure for cell purity, our data confirmed the presence of TGF-β1 in each sample, as previously reported. (Butovsky et al., 2014) We compared gene expression between the naïve controls and naïve LPS-exposed microglial cells and found 258 differentially expressed genes (padj < 0.1), among which, 205 genes were up regulated and 53 were down regulated. We selected relevant differentially expressed genes with ToppCluster (LogP > 4.00) based on their role in the immune response (Figure 3a, b) .
We queried the list of DE genes in the STRING database containing known and predicted protein-protein interactions. Protein-protein network interaction is a statistical, not a causal, representation of a high likelihood that these networks and pathways are either active or inactive together, thus data should be interpreted with care and validated by other means. Our analysis of protein-protein interaction suggests that among DE down regulated genes in naïve microglia, HMOX1 and FOS are likely directly interacting with each other (Figure 3b ). Further downstream analysis through the Reactome (Croft et al., 2014) suggests that the pathway G alpha (i) signaling events (p-Value 9.37 x 10 -3 ) is potentially affected by DE down regulated genes and thus inactive.
We also enriched this dataset for Biological process and Molecular function with Gorilla. The immune system process (GO:0002376, p-Value 5.8 x 10 -5 ) seemed likely affected by the down regulation of genes: CSF1R, FOS, CD300E, RGS1, CXCR4, HMOX1, SLC40A1, DOX2, MERTK, PPARG. However further biochemical studies will be necessary to better understand how the downregulation of these genes is important in the immune system homeostasis.
Enrichment for pathways with Panther revealed that inflammation mediated by chemokine and cytokine signaling pathway is affected by DE down regulated genes (Figure 4 ).
Upregulation of inflammatory and energy-sensing pathways JAK-STAT, NFKB and AMPK
Our GO and protein-protein interaction network analyses of DE genes in naïve microglia also revealed that statistically significant up regulation of inflammatory pathways, NFκB, PIK3-Akt and Jak-STAT was accompanied by a down regulation of metabolic pathways in LPS-induced inflammatory response ( Figure 3a and Table 1 ).
Discussion
We established for the first time an in vivo-in vitro (multi-hit) model of LPS exposure in mammalian microglia and astrocytes to mimic antenatal neuroinflammation. The LPS-induced inflammation is presented as an example of a possible in vivo -in vitro intervention and can be substituted by any other manipulation, such as a viral agent, a drug or an environmental stressor.
The isolation of viable and highly purified microglia and astrocytes populations from in vivo exposed or non-exposed brain allowed an in vitro characterization of those cell types.
In vivo -in vitro model of perinatal inflammation
Experimentally induced inflammation in chronically instrumented non-anesthetized fetal sheep is a well-established and highly translational in vivo model of fetal physiology. (Prout et al., 2010) , (Prout et al., 2012) Primary microglia cultures in different species have been reported for decades. (Stansley et al., 2012) We integrated both in vivo and in vitro models into a new, hybrid system adding the layer of the whole genome analysis using RNAseq. The chief advantage of the new in vivo -in vitro model presented here is that it allows us to examine microglia and astrocyte responses to LPS-induced double-hit inflammation in situ and in vitro on integrative physiological, protein and genomic levels and in a physiologically and clinically meaningful context. This approach has the potential to uncover hitherto unseen relationships between brain and immune system on different scales of organization in the perinatal stage of development, which might accelerate discovery of new treatment strategies.
In vitro, we developed a new microglia and astrocyte isolation protocol that combines the human adult and fetal brain microglia isolation protocols (Durafourt et al., 2013) and successfully collected a highly enriched microglia and astrocytes population. The use of a modified cell isolation approach from fetal brain tissue is mainly due to the higher degree of myelination in the adult human brain compared to that of a near-term fetus. (Durafourt et al., 2013) We were able to attain high purity of microglia and astrocytes, which we validated by immunocytochemistry.
Moreover, RNAseq analysis of microglia showed a consistent and constant low level of expression of the astrocyte marker GFAP further confirming cell purity. We already deployed this approach on microglia. Here, we present this microglia paradigm in protocol-level detail and, for the first time, report on the methodology required to derive pure astrocyte cultures as well.
Methodological considerations
Microglia in vitro have been shown to secrete IL-1β preferentially when challenged with LPS, while IL-6 secretion is a hallmark of cultured astrocytes in rat. (Gottschall et al., 1994) Our findings are consistent with literature and further support the cell culture purity. Aside of being efficient at achieving cell purity, the physicochemical cell purification method we present helps avoid any spurious alteration of cell properties in vitro that may occur with immunological separation techniques such as beads. Nevertheless, caution must be exerted when translating findings made in primary in vitro cultures onto in vivo systems.
In parallel to our team, the feasibility of creating a mixed primary fetal ovine brain culture has been recently demonstrated. (Weaver-Mikaere et al., 2012) We have advanced this work by focusing on late rather than mid-gestation fetuses and creating primary pure microglial culture rather than mixed culture. This allowed us to then study the microglia-specific effects on the secretion profile of the inflammatory cytokine IL-1β and the sequencing at high-throughput of microglia transcriptome as a proof-of-principle.
In our approach, we used DESeq2 to normalize read counts and identify differentially expressed genes. DESeq2 was specifically designed to normalize and estimate the dispersion and differential expression in a dataset containing replicates for both control and treatment samples. Despite quality control measures prior to sequencing, the sample NL3 had a different expression pattern than the two other NL samples. We believe this is not related to RNA quality, and may have been due to environmental or other physiological conditions of the animal that we were not aware of at the time of the experiment. In interrogating the differential gene expression, we have ensured that the partially deviating pattern observed in sample NL3 did not confound our findings (Figure 3a,b) .
Conclusions
The presented multi-hit fetal sheep model and the genomic analysis workflow allow studying mechanisms of fetal neuroinflammation or other multi-hit fetal injury paradigms in vivo and in vitro to identify potential biomarkers, mechanisms and therapeutic targets for early postnatal intervention to prevent lasting brain injury. 
